Evidence map›Paper›PMID 40498210›Full record

ArticleLasers in medical science2025

Predicting risk of treatment non-adherence in patients receiving intense light therapy: development and evaluation of a new predictive nomogram.

Yang Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Yang ZhangForesea Life Insurance Guangzhou General Hospital, Guangzhou City, China. joshuayangzhang@qq.com.

Funding

Health Science and Technology Project of Guangzhou City 20241A010119
6 · The paper itself

Abstract

backgroundThis study aimed to develop and validate a treatment non-adherence risk nomogram for patients receiving intense pulsed light (IPL) therapy, utilizing internal bootstrap validation and external independent set validation. PATIENTS AND

methodsWe analyzed data from 316 patients who received IPL therapy between January and December 2021. The dataset was divided into a training set (n = 213, 67.41%) for model development and a validation set (n = 103, 32.59%). Twenty-two variables spanning demographics, clinical consultations/treatments, and personal habits were evaluated. A multivariable logistic regression model was constructed using predictors selected via Least Absolute Shrinkage and Selection Operator (LASSO) regression. Model performance was assessed by discrimination (C-index), calibration (calibration curves), and clinical utility (decision curve analysis, DCA). Internal validation employed 1,000 bootstrap resamples, followed by external validation.

resultsLASSO regression identified seven predictors: number of jewels, local residents, unrealistic demands, undergone plastic surgery, regular physical exercise, awareness of sun protection, and carbonated/sugary drinks. The nomogram demonstrated strong discrimination (training C-index: 0.922, 95% CI: 0.888-0.956; modified C-index: 0.896) and excellent calibration. External validation confirmed robustness (C-index: 0.897, 95% CI: 0.832-0.962). DCA revealed superior net benefit at threshold probabilities of 1-100% (training) and 1-88% (validation), supporting clinical utility.

conclusionThis validated nomogram provides a practical tool for individualized prediction of IPL therapy non-adherence risk, facilitating targeted interventions to improve treatment adherence.

Indexed as

NomogramsPatient CompliancePhototherapyAdultAgedFemaleHumansMaleMiddle AgedIntense pulsed lightNomogramPredictorsTreatment non-adherence

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.